DEA Says No to Delta-8

DEA Says No to Delta-8

The DEA has recently confirmed that it believes delta-8 THC synthesized from CBD is federally illegal. This is based on a 2021 letter from DEA’s Drug & Chemical Evaluation Section Chief Terrence Boos. Boos states, “Arriving at delta-8-THC by a chemical reaction starting from CBD makes the delta-8-THC synthetic and therefore, not exempted by the Agriculture Improvement Act. Any quantity of delta-8-THC obtained by chemical means is a controlled substance.” Hemp itself is considered a legal agricultural product under the 2018 Farm Bill.

The DEA’s position is based on the Controlled Substances Act (CSA), which defines a “synthetic drug” as “a drug that is not naturally occurring and that is chemically made.” The DEA argues that delta-8 THC is not naturally occurring in hemp, and that it is therefore a synthetic drug.

The DEA’s position is controversial, and there is some legal debate about whether it is correct. However, the DEA has the authority to enforce the CSA, and it is likely that they will continue to pursue cases against businesses that sell delta-8 THC synthesized from CBD.

In other news, a complaint filed in Connecticut seeks to overturn cannabis legalization in the state’s Supreme Court, citing the federal prohibition under the Controlled Substances Act.

Alabama, Minnesota and Ohio also make an appearance in the headlines. Health news in cannabis gives users some peace of mind with the results of a new analysis. Other stories await as well as an all new Name That Strain on this week’s episode of Cannabis Legalization News with hosts Tom Howard and Miggy 420.

Get in touch with us:
???? We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base)
???? Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr)
???? Become a member for exclusive perks! (https://bit.ly/2UavaLj
???? Learn more about the ???? Industry! (http://bit.ly/3Jo4VIz)

#cannabislegalization

#cannabisnews

#marijuanareform

Spread the love
Picture of Thomas Howard

Thomas Howard

a seasoned cannabis business attorney, entrepreneur, and advocate with over a decade of hands-on experience navigating complex cannabis regulations across the United States. As the founder of Cannabis Industry Lawyer and co-host of Cannabis Legalization News, Tom has helped clients win cannabis licenses in multiple states, advised startups from seed to sale, and litigated key industry cases involving constitutional challenges and regulatory disputes. He’s personally built and launched cannabis businesses, giving him a rare combination of legal expertise and real-world operational insight. Tom has studied thousands of pages of cannabis laws and rules, testified on legalization issues, and regularly appears in media to break down developments in plain English. His mission: to fight outdated prohibition, empower entrepreneurs, and provide trustworthy, actionable information to anyone building a future in the legal cannabis industry.
Picture of Thomas Howard

Thomas Howard

a seasoned cannabis business attorney, entrepreneur, and advocate with over a decade of hands-on experience navigating complex cannabis regulations across the United States. As the founder of Cannabis Industry Lawyer and co-host of Cannabis Legalization News, Tom has helped clients win cannabis licenses in multiple states, advised startups from seed to sale, and litigated key industry cases involving constitutional challenges and regulatory disputes. He’s personally built and launched cannabis businesses, giving him a rare combination of legal expertise and real-world operational insight. Tom has studied thousands of pages of cannabis laws and rules, testified on legalization issues, and regularly appears in media to break down developments in plain English. His mission: to fight outdated prohibition, empower entrepreneurs, and provide trustworthy, actionable information to anyone building a future in the legal cannabis industry.

Related Posts

0
    0
    Your Cart
    Your cart is emptyReturn to Shop

    Subscribe to our Newsletter